Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Hinge Health Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Hinge Health Inc (HNGE) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
53.37 %
Q2 2026
Net Margin
20.25 %
Q2 2026

Key Findings: Hinge Health Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 720M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+18.2% annualized vs trailing 12 months).
  • Scale: Hinge Health Inc ranks #19 of 165 companies by market capitalization in the Cloud Computing & Data Analytics industry, holding 1.2% of industry market cap.
  • Peer revenue share: Hinge Health Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

HNGE Sales vs. its Competitors, Q2 2026

Hinge Health Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/HNGE/competitors
https://api.csimarket.com/api/v1/companies/HNGE/relationships
https://api.csimarket.com/api/v1/companies/HNGE/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Cloud Computing & Data Analytics industry grew revenue 1.3% year over year, combined, vs 53.4% for Hinge Health Inc. Hinge Health Inc's share of combined industry revenue moved from 0.10% to 0.15%, a gain of 0.05 percentage points.

Hinge Health Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Hinge Health Inc Yes Yes Yes No
High-Confidence Competitors (3) 67% 67% 67% 33%
Similar-Size Competitors (10) 63% 78% 67% 10%
Similar Growth & Profitability (8) 100.00 % (8 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 0.00 % (0 of 6)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

100%market share
  • Hinge Health Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Hinge Health Inc and its 0 tracked competitors.

See Hinge Health Inc's full market share breakdown »

HNGE Stock Performance relative to its Competitors

HNGE Competitors (weighted) Percent change over the selected range

Hinge Health Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
High-Confidence
(0 of 3)
10%beat U.S.A. 500
Similar-Size
(1 of 10)
25%beat U.S.A. 500
Similar Growth & Profitability
(1 of 4)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Hinge Health Inc 81.30 % Outperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (3) 40.4% 63.2%
Similar-Size Competitors (10) 40.4% 63.2%
Similar Growth & Profitability (4) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Hinge Health Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

HNGE Stock Performance relative to High-Confidence Competitors

HNGE High-Confidence Competitors (equal-weighted, 3) Percent change over the selected range

HNGE Stock Performance relative to Similar-Size Competitors

HNGE Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

HNGE Stock Performance relative to Similar Growth & Profitability Competitors

HNGE Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Hinge Health Inc's Comment on Competition and Industry Peers

The company operates in the technology platform market for joint and muscle pain (MSK) conditions, which is competitive and rapidly evolving. Competitors include digital platforms offering broad or segment-specific MSK care, such as Kaia Health Software, Inc. (acquired by Sword Health Technologies, Inc. in January 2026), Omada Health, Inc., Sword Health Technologies, Inc., and Vori Health, Inc. Additionally, health plans and health systems may provide or develop similar products or services.

Hinge Health Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Kaia Health Software, Inc. Named by the company 85% 2022 to 2026 3
Dariohealth Corp Named by the company 85% 2022 to 2026 3
Vori Health, Inc. Named by the company 85% 2022 to 2026 3
Omada Health, Inc. Named by the company 85% 2022 to 2026 3
Grindr Inc Named by the company 85% 2022 to 2026 3
Sword Health Technologies, Inc. Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Hinge Health Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.